Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Sell
29
ALB Quote, Financials, Valuation and Earnings
Last price:
$58.35
Seasonality move
:
2.59%
Day range:
$57.64 - $60.20
52-week range:
$49.43 - $137.50
Dividend yield:
2.79%
P/E ratio:
43.27x
P/S ratio:
1.34x
P/B ratio:
0.87x
Volume:
2.6M
Avg. volume:
3.7M
1-year change:
-54.77%
Market cap:
$6.8B
Revenue:
$5.4B
EPS (TTM):
-$11.12
Albemarle Number of Institutional Trades
Albemarle Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$16.9B
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$25.8B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Albemarle Institutional Ownership
-
What Percentage Of ALB Is Owned by Institutions?
-- of ALB is owned by institutions.
-
How Many Institutions Own ALB Shares?
Albemarle stock is owned by 1,641 institutional shareholders at this time.
-
Have Institutions Been Buying ALB Stock?
Yes, institutions have bought 101.6M shares of ALB in the last quarter.
-
Have Institutions Been Selling ALB Stock?
Yes, institutions have sold 164.2M shares of ALB over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Is RTX The Best Growth Stock?
Among the worldwide aerospace and defense markets, the US controls…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 6
Regencell Bioscience Holdings [RGC] is up 85.19% over the past day.
Buy
63
SKX alert for May 6
Skechers USA [SKX] is up 0.02% over the past day.
Sell
20
PTCT alert for May 6
PTC Therapeutics [PTCT] is down 2.56% over the past day.
